These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 22718357)

  • 1. Pharmacy syringe purchase test of nonprescription syringe sales in San Francisco and Los Angeles in 2010.
    Lutnick A; Cooper E; Dodson C; Bluthenthal R; Kral AH
    J Urban Health; 2013 Apr; 90(2):276-83. PubMed ID: 22718357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacy participation in non-prescription syringe sales in Los Angeles and San Francisco counties, 2007.
    Cooper EN; Dodson C; Stopka TJ; Riley ED; Garfein RS; Bluthenthal RN
    J Urban Health; 2010 Jul; 87(4):543-52. PubMed ID: 20549568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Self-reported participation in voluntary nonprescription syringe sales in California's Central Valley.
    Pollini RA
    J Am Pharm Assoc (2003); 2017; 57(6):677-685. PubMed ID: 28807658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Access to sterile syringes through San Francisco pharmacies and the association with HIV risk behavior among injection drug users.
    Riley ED; Kral AH; Stopka TJ; Garfein RS; Reuckhaus P; Bluthenthal RN
    J Urban Health; 2010 Jul; 87(4):534-42. PubMed ID: 20526690
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of nonprescription syringe sales in San Francisco.
    Rose VJ; Raymond HF
    J Am Pharm Assoc (2003); 2010; 50(5):595-9. PubMed ID: 20833617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nonprescription syringe sales: a missed opportunity for HIV prevention in California.
    Pollini RA; Rudolph AE; Case P
    J Am Pharm Assoc (2003); 2015; 55(1):31-40. PubMed ID: 25575149
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of increased syringe access: preliminary findings on injection drug user syringe source, disposal, and pharmacy sales in Harlem, New York.
    Fuller CM; Ahern J; Vadnai L; Coffin PO; Galea S; Factor SH; Vlahov D
    J Am Pharm Assoc (Wash); 2002; 42(6 Suppl 2):S77-82. PubMed ID: 12489621
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of legal status of pharmacy syringe sales on syringe purchases by persons who inject drugs in San Francisco and San Diego, CA.
    Siddiqui SS; Armenta RF; Evans JL; Yu M; Cuevas-Mota J; Page K; Davidson P; Garfein RS
    Int J Drug Policy; 2015 Nov; 26(11):1150-7. PubMed ID: 26252980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Access to syringes for HIV prevention for injection drug users in St. Petersburg, Russia: syringe purchase test study.
    Fedorova EV; Skochilov RV; Heimer R; Case P; Beletsky L; Grau LE; Kozlov AP; Shaboltas AV
    BMC Public Health; 2013 Mar; 13():183. PubMed ID: 23452390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. I could take the judgment if you could just provide the service: non-prescription syringe purchase experience at Arizona pharmacies, 2018.
    Meyerson BE; Lawrence CA; Cope SD; Levin S; Thomas C; Eldridge LA; Coles HB; Vadiei N; Kennedy A
    Harm Reduct J; 2019 Sep; 16(1):57. PubMed ID: 31533730
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacy access to syringes among injecting drug users: follow-up findings from Hartford, Connecticut.
    Singer M; Baer HA; Scott G; Horowitz S; Weinstein B
    Public Health Rep; 1998 Jun; 113 Suppl 1(Suppl 1):81-9. PubMed ID: 9722813
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Syringe disposal among people who inject drugs in Los Angeles: the role of sterile syringe source.
    Quinn B; Chu D; Wenger L; Bluthenthal RN; Kral AH
    Int J Drug Policy; 2014 Sep; 25(5):905-10. PubMed ID: 24930425
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An economic analysis of needle exchange and pharmacy-based programs to increase sterile syringe availability for injection drug users.
    Lurie P; Gorsky R; Jones TS; Shomphe L
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S126-32. PubMed ID: 9663635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demographic, risk, and spatial factors associated with over-the-counter syringe purchase among injection drug users.
    Stopka TJ; Lutnick A; Wenger LD; Deriemer K; Geraghty EM; Kral AH
    Am J Epidemiol; 2012 Jul; 176(1):14-23. PubMed ID: 22562660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonprescription syringe sales: Resistant pharmacists' attitudes and practices.
    Chiarello E
    Drug Alcohol Depend; 2016 Sep; 166():45-50. PubMed ID: 27423213
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New York City pharmacists' attitudes toward sale of needles/syringes to injection drug users before implementation of law expanding syringe access.
    Coffin PO; Linas BP; Factor SH; Vlahov D
    J Urban Health; 2000 Dec; 77(4):781-93. PubMed ID: 11194317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Feasibility of providing interventions for injection drug users in pharmacy settings: a case study among San Francisco pharmacists.
    Rose VJ; Lutnick A; Kral AH
    J Psychoactive Drugs; 2014; 46(3):226-32. PubMed ID: 25052881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacists' attitudes about pharmacy sale of needles/syringes and needle exchange programs in a city without needle/syringe prescription laws.
    Gleghorn AA; Gee G; Vlahov D
    J Acquir Immune Defic Syndr Hum Retrovirol; 1998; 18 Suppl 1():S89-93. PubMed ID: 9663630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of increased legal access to needles and syringes on community pharmacies' needle and syringe sales--Connecticut, 1992-1993.
    Valleroy LA; Weinstein B; Jones TS; Groseclose SL; Rolfs RT; Kassler WJ
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Sep; 10(1):73-81. PubMed ID: 7648288
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Racial differences in acquisition of syringes from pharmacies under conditions of legal but restricted sales.
    Costenbader EC; Zule WA; Coomes CC
    Int J Drug Policy; 2010 Sep; 21(5):425-8. PubMed ID: 20097052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.